DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Sconce EA, Khan TI, Wynne HA. et al.
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.
Blood 2005;
106: 2329-2333.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.